SCHEMBL4899847

SCHEMBL4899847

CCC=C(C(N)=O)N(C)C

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.31
GRIK2 Q13002 1/20 0.31
FAAH O00519 2/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL407636 1.00 GRIK1 (0.31) GRIK1GRIK2FAAHALDH1A1
Hydrochloric Acid SCHEMBL27829253 0.98 GRIK1 (0.31) GRIK1GRIK2
Chloromethane SCHEMBL6934346 0.96 ALDH1A1 (0.31) ALDH1A1
Bicarbonate SCHEMBL9017529 0.96 GRIK1 (0.33) GRIK1GRIK2
SCHEMBL23742580 0.84 GRIK1 (0.31) GRIK1GRIK2
SCHEMBL27514525 0.82 GRIK1 (0.35) GRIK1GRIK2FAAHALDH1A1
SCHEMBL93436 0.82 GRIK1 (0.35) GRIK1GRIK2FAAHALDH1A1
SCHEMBL4901298 0.79 LMNA (0.34) GRIK1GRIK2
SCHEMBL2503815 0.79 LMNA (0.34) GRIK1GRIK2
Chloromethane SCHEMBL1333197 0.79 GRIK1 (0.33) GRIK1GRIK2FAAHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667784-B2 Copolymers including cinchona alkaloid components and one or more acrylamide or acrylate containing components, complexes containing the same, and methods of using the REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2023-06-06 US disclosed
CN-114656378-A Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids 得克萨斯州大学系统董事会 2022-06-24 CN disclosed
CN-109414408-B Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids 得克萨斯州大学系统董事会 2022-03-29 CN disclosed
CN-112912420-A Polymer composition 巴斯夫欧洲公司 2021-06-04 CN disclosed
US-20190153212-A1 COPOLYMERS INCLUDING CINCHONA ALKALOID COMPONENTS AND ONE OR MORE ACRYLAMIDE OR ACRYLATE CONTAINING COMPONENTS, COMPLEXES CONTAINING THE SAME, AND METHODS OF USING THE SAME REGENTS OF THE UNIVERSITY OF MINNESOTA 2019-05-23 US disclosed
CN-109642147-A Method of producing a composite material BP探索操作有限公司 2019-04-16 CN disclosed
CN-109414408-A CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS 得克萨斯州大学系统董事会 2019-03-01 CN disclosed
US-20080194715-A1 Use of Copolymers Comprising Polyisobutene in Cosmetic Compositions BASF AKTIENGESELLSCHAFT (DE) 2008-08-14 US disclosed
EP-1530600-A1 BIO-SYNTHETIC MATRIX AND USES THEREOF Ottawa Health Research Institute (CA) 2005-05-18 EP disclosed
WO-2004014969-A1 BIO-SYNTHETIC MATRIX AND USES THEREOF OTTAWA HEALTH RESEARCH INSTITUTE (CA) 2004-02-19 WO disclosed
US-4632897-A Photopolymerizable recording material suitable for the production of photoresist layers BASF AKTIENGESELLSCHAFT (DE) 1986-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667784-B2 Copolymers including cinchona alkaloid components and one or more acrylamide or acrylate containing components, complexes containing the same, and methods of using the BRCA1, DCLRE1A, NIPSNAP3A GRIK1 1146/4885GRIK2 1323/4885FAAH 4461/4885
US-20190153212-A1 COPOLYMERS INCLUDING CINCHONA ALKALOID COMPONENTS AND ONE OR MORE ACRYLAMIDE OR ACRYLATE CONTAINING COMPONENTS, COMPLEXES CONTAINING THE SAME, AND METHODS OF USING THE SAME PCNA, NCLN, CROCC GRIK1 603/4885GRIK2 862/4885FAAH 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.